Tumor suppressor gene-based nanotherapy: from test tube to the clinic.

J Drug Deliv · 2011 · PMC3065904 · PMID 21490751

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As shown in Figure 3 , mice receiving IL-24-containing nanocarrier showed a trend for increased survival compared to all other treatment groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.